1. 1. The rat paw oedema produced by a local injection of phospholipase A2 from Naja mocambique mocambique has been shown to be mainly driven by the liberation of serotonin and kinins. 2. 2. Using specific bradykinin receptor antagonists we have shown that kinins are acting through B2 receptors. 3. 3. Using endothelium-derived relaxing factor (EDRF) synthesis inhibitors NG-monomethyl-l-arginine and l-NG-nitro arginine we have tested the possible envolvement of EDRF as mediator. 4. 4. Our work supports the view that extracellular phospholipases A2 are involved in inflammation, and suggests a role for EDRF as mediator of extravasation in this model of inflammation

Effect of bradykinin antagonists, NG- monomethyl-L- Arginine and L- NG- Nitro - Arginine on phospholipase A2 induced oedema in rat paw / Cirino, Giuseppe; Cicala, Carla; Sorrentino, L; Regoli, D.. - In: GENERAL PHARMACOLOGY. - ISSN 0306-3623. - STAMPA. - 22:5(1991), pp. 801-804. [10.1016/0306-3623(91)90209-O]

Effect of bradykinin antagonists, NG- monomethyl-L- Arginine and L- NG- Nitro - Arginine on phospholipase A2 induced oedema in rat paw.

CIRINO, GIUSEPPE;CICALA, CARLA;
1991

Abstract

1. 1. The rat paw oedema produced by a local injection of phospholipase A2 from Naja mocambique mocambique has been shown to be mainly driven by the liberation of serotonin and kinins. 2. 2. Using specific bradykinin receptor antagonists we have shown that kinins are acting through B2 receptors. 3. 3. Using endothelium-derived relaxing factor (EDRF) synthesis inhibitors NG-monomethyl-l-arginine and l-NG-nitro arginine we have tested the possible envolvement of EDRF as mediator. 4. 4. Our work supports the view that extracellular phospholipases A2 are involved in inflammation, and suggests a role for EDRF as mediator of extravasation in this model of inflammation
1991
Effect of bradykinin antagonists, NG- monomethyl-L- Arginine and L- NG- Nitro - Arginine on phospholipase A2 induced oedema in rat paw / Cirino, Giuseppe; Cicala, Carla; Sorrentino, L; Regoli, D.. - In: GENERAL PHARMACOLOGY. - ISSN 0306-3623. - STAMPA. - 22:5(1991), pp. 801-804. [10.1016/0306-3623(91)90209-O]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/132892
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact